Skip to main content
SpringerLink
Log in

The Role of NMDA Receptors in Opiate Tolerance, Sensitization, and Physical Dependence

A Review of the Research, A Cellular Model, and Implications for the Treatment of Pain and Addiction

  • Chapter
Glutamate and Addiction

Part of the book series: Contemporary Clinical Neuroscience ((CCNE))

  • 226 Accesses

Abstract

When administered acutely, opiates such as morphine produce characteristic behavioral effects, including a decrease in pain responsiveness (analgesia) and an increase in pleasure (euphoria). Because of their profound ability to produce analgesia, opiates are the drugs of choice for the treatment of severe or chronic pain. Because of their ability to produce positive reinforcement and pleasure, these drugs are widely self-administered and, therefore, represent an important class of abused drugs. Long-term treatment with opiates, as well as other drugs of abuse, leads to three well-known consequences: tolerance, which is a decrease in an effect of a drug with chronic use; sensitization, which is an increase in an effect of drug with chronic use; and physical dependence, which is a physiological change produced by chronic use, such that the absence of the drug results in an unpleasant withdrawal syndrome* (1–3). Tolerance, sensitization, and physical dependence are important in both the clinical use of opiates and in their self-administration. For example, the development of tolerance to the analgesic effect of opiates may lead to the need to escalate the dose during the treatment of chronic pain, whereas tolerance to the euphorigenic effect may be a factor in the escalation of drug use in addicts (4). Conversely, tolerance to dose-limiting side effects may allow addicts to escalate drug intake and achieve greater euphorigenic effects. The development of sensitization is thought to be involved in the craving that occurs following chronic use of drugs of abuse and, therefore, critical to addiction (5,6). Finally, the avoidance of withdrawal in physically dependent individuals is considered to be an important factor in maintaining self-administration (2,4).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Stewart, J. and Badiani, A. (1993) Tolerance and sensitization to the behavioral effects of drugs. Behay. Pharmacol. 4, 289–312.

    CAS  Google Scholar 

  2. Trujillo, K. A. and Akil, H. (1995) Excitatory amino acids and drugs of abuse: a role for N-methyl-D-aspartate receptors in drug tolerance, sensitization and physical dependence. Drug Alcohol Depend. 38, 139–154.

    Article  PubMed  CAS  Google Scholar 

  3. Trujillo, K. A. and Akil, H. (1991) Opiate tolerance and dependence: recent findings and synthesis. New Biol. 3, 915–923.

    PubMed  CAS  Google Scholar 

  4. Schulteis, G. and Koob, G. F. (1996) Reinforcement processes in opiate addiction: a homeostatic model. Neurochem. Res. 21, 1437–1454.

    Article  PubMed  CAS  Google Scholar 

  5. Robinson, T. E. and Berridge, K. C. (1993) The neural basis of drug craving: an incentive-sensitization theory of drug craving. Brain Res. Rev. 18, 247–291.

    Article  PubMed  CAS  Google Scholar 

  6. Wolf, M. E. (1998) The role of excitatory amino acids in behavioral sensitization to psychomotor stimulants. Prog. Neurobiol. 54, 679–720.

    Article  PubMed  CAS  Google Scholar 

  7. Collingridge, G. L. and Watkins, J. C. (1994) The NMDA receptor 2nd ed., Oxford University Press, New York.

    Google Scholar 

  8. Meldrum, B. S. (1991) Excitatory amino acid antagonists, in Frontiers in Pharmacology and Therapeutics, Blackwell Scientific, Boston.

    Google Scholar 

  9. Seeburg, P. H. (1993) The TINS/TIPS Lecture: the molecular biology of mammalian glutamate receptor channels. Trend Neurosci. 16, 359–365.

    Article  PubMed  CAS  Google Scholar 

  10. Collingridge, G. L. and Lester, R. A. J. (1989) Excitatory amino acid receptors in the vertebrate central nervous system. Pharmacol. Rev. 41, 143–210.

    PubMed  CAS  Google Scholar 

  11. Michaelis, E. K. (1998) Molecular biology of glutamate receptors in the central nervous system and their role in excitotoxicity, oxidative stress and aging. Prog. Neurobiol. 54, 369–415.

    Article  PubMed  CAS  Google Scholar 

  12. Yamakura, T. and Shimoji, K. (1999) Subunit-and site-specific pharmacology of the NMDA receptor channel. Prog. Neurobiol. 59, 279–298.

    Article  PubMed  CAS  Google Scholar 

  13. Dingledine, R., Borges, K., Bowie, D., and Traynelis, S. F. (1999) The glutamate receptor ion channels. Pharmacol. Rev. 51, 7–61.

    PubMed  CAS  Google Scholar 

  14. Artola, A. and Singer, W. (1993) Long-term depression of excitatory synaptic transmission and its relationship to long-term depression. Trends Neurosci. 16, 480–487.

    Article  PubMed  CAS  Google Scholar 

  15. McMahon, S. B., Lewin. G. R., and Wall, R D. (1993) Central hyperexicitability triggered by noxious inputs. Curr. Opin. Neurobiol. 3, 602–610.

    Article  CAS  Google Scholar 

  16. Malenka, R. C. and Nicoll, R. A. (1993) NMDA-receptor-dependent synaptic plasticity: multiple forms and mechanisms. Trends Neurosci. 16, 521–527.

    Article  PubMed  CAS  Google Scholar 

  17. Coderre, T. J., Katz, J., Vaccarino, A. L., and Melzack, R. (1993) Contribution of central neuroplasticity to pathological pain: review of clinical and experimental evidence. Pain 53, 259–285.

    Article  Google Scholar 

  18. McDonald, J. W. and Johnston, M. V. (1990) Physiological and pathophysiological roles of excitatory amino acids during central nervous system development. Brain Res. Rev. 15, 41–70.

    Article  PubMed  Google Scholar 

  19. Crepel, V., Congar, P., Aniksztejn, L., et al. (1998) Synaptic plasticity in ischemia: role of NMDA receptors. Frog. Brain Res. 116, 273–285.

    Article  CAS  Google Scholar 

  20. Abraham, W. C. and Bear, M. F. (1996) Metaplasticity: the plasticity of synaptic plasticity Trends Neurosci. 19, 126–130.

    Article  PubMed  CAS  Google Scholar 

  21. Bear, M. F. (1996) NMDA-receptor-dependent synaptic plasticity in the visual cortex. Prog. Brain Res. 108, 205–218.

    Article  PubMed  CAS  Google Scholar 

  22. Dickenson, A. H. (1995) Central acute pain mechanisms. Ann. Med. 27, 223–227.

    Article  PubMed  CAS  Google Scholar 

  23. Bear, M. F. and Malenka, R. C. (1994) Synaptic plasticity: LTP and LTD. Curr. Opin. Neurobiol. 4, 389–399.

    Article  PubMed  CAS  Google Scholar 

  24. Davis, M., Falls, W. A., Campeau, S., and Kim, M. (1993) Fear-potentiated startle: a neural and pharmacological analysis. Behay. Brain Res. 58, 175–198.

    Article  CAS  Google Scholar 

  25. Trujillo, K. A. and Akil, H. (1991) Inhibition of morphine tolerance and dependence by the NMDA receptor antagonist MK-801. Science 251, 85–87.

    Article  PubMed  CAS  Google Scholar 

  26. Marek, P., Ben-Eliyahu, S., Gold, M., and Liebeskind, J. C. (1991) Excitatory amino acid antagonists (kynurenic acid and MK-801) attenuate the development of morphine tolerance in the rat. Brain Res. 547, 77–81.

    Article  PubMed  CAS  Google Scholar 

  27. Marek, P., Ben-Eliyahu, S., Vaccarino, A. L., and Liebeskind, J. C. (1991) Delayed application of MK-801 attenuates development of morphine tolerance in rats. Brain Res. 558, 163–165.

    Article  PubMed  CAS  Google Scholar 

  28. Trujillo, K. A., Warmoth, K. P., Peterson, D. J., Albertson, D. N., and Swadley-Lewellen, R. M. (2000) NMDA receptor blockade mimics tolerance to the locomotor effects of morphine. International Narcotics Research Conference, Seattle, WA.

    Google Scholar 

  29. Bhargava, H. N. and Matwyshyn, G. A. (1993) Dizocilpine (MK-801) blocks tolerance to the analgesic but not to the hyper-thermic effect of morphine in the rat. Pharmacology. 47, 344–350.

    Article  PubMed  CAS  Google Scholar 

  30. Gutstein, H. B. and Trujillo, K. A. (1993) MK-801 inhibits the development of morphine tolerance at spinal sites. Brain Res. 626, 332–334.

    Article  PubMed  CAS  Google Scholar 

  31. Kest, B., Mogil, J. S., Shamgar, B.-E., et al. (1993) The NMDA receptor antagonist MK-801 protects against the development of morphine tolerance after intrathecal administration. Proc. West. Pharmacol. Soc. 36, 307–310.

    PubMed  CAS  Google Scholar 

  32. Lutfy, K., Hurlbut, D. E., and Weber, E. (1993) Blockade of morphine-induced analgesia and tolerance in mice by MK-801. Brain Res. 616, 83–88.

    Article  PubMed  CAS  Google Scholar 

  33. Tiseo, P. J. and Inturrisi, C. E. (1993) Attenuation and reversal of morphine tolerance by the competitive N-methyl-D-aspartate receptor antagonist LY274614. J. Pharmacol. Exp. Ther. 264, 1090–1096.

    PubMed  CAS  Google Scholar 

  34. Elliott, K., Minami, N., Kolesnikov, Y. A., Pasternak, G. W., and Inturrisi, C. E. (1994) The NMDA receptor antagonists, LY274614 and MK-801, and the nitric oxide synthase inhibitor, NG-nitro-L-arginine, attenuate analgesic tolerance to the mu-opioid morphine but not to kappa opioids. Pain 56, 69–75.

    Article  PubMed  CAS  Google Scholar 

  35. Mao, J., Price, D. D., and Mayer, D. J. (1994) Thermal hyperalgesia in association with the development of morphine tolerance in rats: roles of excitatory amino acid receptors and protein kinase C. J. Neurosci. 14, 2301–2312.

    PubMed  CAS  Google Scholar 

  36. Trujillo, K. A. and Akil, H. (1994) Inhibition of opiate tolerance by non-competitive N-methyl-D-aspartate receptor antagonists. Brain Res. 633, 178–188.

    Article  PubMed  CAS  Google Scholar 

  37. Mao, J., Price, D. D., Phillips, L. L., Lu, J., and Mayer, D. J. (1995) Increases in protein kinase C immunoreactivity in the spinal cord of rats associated with tolerance to the analgesic effects of morphine. Brain Res. 677, 257–267.

    Article  PubMed  CAS  Google Scholar 

  38. Verma, A. and Kulkami, S. K. (1995) Role of D1/D2 dopamine and N-methyl-D-aspartate (NMDA) receptors in morphine tolerance and dependence in mice. Eur. Neuropsychopharmacol 5, 81–87.

    Article  PubMed  CAS  Google Scholar 

  39. Bilsky, E. J., Inturrisi, C. E., Sadee, W., Hruby, V. J., and Porreca, R (1996) Competitive and non-competitive NMDA antagonists block the development of antinociceptive tolerance to morphine, but not to selective µ or S opioid agonists in mice. Pain 68, 229–237.

    Article  PubMed  CAS  Google Scholar 

  40. Dunbar, S. and Yaksh, T. L. (1996) Concurrent spinal infusion of MK801 blocks spinal tolerance and dependence induced by chronic intrathecal morphine in the rat. Anesthesiology 84, 1177–1188.

    Article  PubMed  CAS  Google Scholar 

  41. Lutfy, K., Shen, K. Z., Woodward, R. M., and Weber, E. (1996) Inhibition of morphine tolerance by NMDA receptor antagonists in the formalin test. Brain Res. 731, 171–181.

    Article  PubMed  CAS  Google Scholar 

  42. Manning, B. H., Mao, J., Frenk, H., Price, D. D., and Mayer, D. J. (1996) Continuous co-administration of dextromethorphan or MK-801 with morphine: attenuation of morphine dependence and naloxone-reversible attenuation of morphine tolerance. Pain 67, 79–88.

    Article  PubMed  CAS  Google Scholar 

  43. Wong, C.-S., Chemg, C.-H., Luk, H. N., Ho, S.-T., and Tung, C.-S. (1996) Effects of NMDA receptor antagonists on inhibition of morphine tolerance in rats: binding at.t-opioid receptors. Eur. J. Pharmacol. 297, 27–33.

    Article  PubMed  CAS  Google Scholar 

  44. Fairbanks, C. A. and Wilcox, G. L. (1997) Acute tolerance to spinally administered morphine compares mechanistically with chronically induced morphine tolerance. J. Pharnutcol. Exp. Thee 282, 1408–1417.

    CAS  Google Scholar 

  45. Gonzalez, P., Cabello, P., Germany, A., Norris, B., and Contreras, E. (1997) Decrease of tolerance to, and dependence on morphine by, glutamate receptor antagonists. Eue. i Pharmacol. 332, 257–262.

    CAS  Google Scholar 

  46. McLemore, G. L., Kest, B., and Inturrisi, C. E. (1997) The effects of LY293558, and AMPA receptor antagonist, on acute and chronic morphine dependence. Brain Res. 778, 120–126.

    Article  PubMed  CAS  Google Scholar 

  47. Vaccarino, A. L. and Clavier, M. C. (1997) Blockade of tolerance to stress-induced analgesia by MK-801 in mice. Pharmacol. Biochem. Behay. 56, 435–439.

    Article  CAS  Google Scholar 

  48. Belozertseva, I. V. and Bespalov, A. (1998) Effects of NMDA receptor channel blockers, dizocilpine and memantine, on the development of opiate analgesic tolerance induced by repeated morphine exposures or social defeats in mice. NaunynSchmiedebergs Arch. Pharmacol. 358, 270–274.

    Article  PubMed  CAS  Google Scholar 

  49. Larcher, A., Laulin, J. P., Celerier, E., Le Moal, M., and Simonnet, G. (1998) Acute tolerance associated with a single opiate administration: involvement of N-methyl-D-aspartate-dependent pain facilitatory systems. Neuroscience 84, 583–589.

    Article  PubMed  CAS  Google Scholar 

  50. McCarthy, R. J., Kroin, J. S., Tuman, K. J., Penn, R. D., and Ivankovich, A. D. (1998) Antinociceptive potentiation and attenuation of tolerance by intrathecal co-infusion of magnesium sulfate and morphine in rats. Anesth. Analg. 86, 830–836.

    PubMed  CAS  Google Scholar 

  51. Mao, J., Price, D. D., Lu, J., and Mayer, D. J. (1998) Antinociceptive tolerance to the mu-opioid agonist DAMGO is dose-dependently reduced by MK-801 in rats. Neurosci. Lett. 250, 193–196.

    Article  PubMed  CAS  Google Scholar 

  52. Kolesnikov, Y. A. and Pasternak, G. W. (1999) Topical opioids in mice: analgesia and reversal of tolerance by a topical Nmethyl-D-aspartate antagonist. J. Pharmacol. Exp. Ther. 290, 247–252.

    PubMed  CAS  Google Scholar 

  53. Koyuncuoglu, H., Nurten, A., Yamanturk, P., and Nurten, R. (1999). The importance of the number of NMDA receptors in the develpment of supersensitivity or tolerance to and dependence on morphine. Pharmacol. Res. 39, 311–319.

    Article  PubMed  CAS  Google Scholar 

  54. Laulin, J. P., Celerier, E., Larcher, A., Le Moal, M., and Simonnet, G. (1999) Opiate tolerance to daily heroin administration: an apparent phenomenon associated with enhanced pain sensitivity. Neuroscience 89, 631–636.

    Article  PubMed  CAS  Google Scholar 

  55. Shimoyama, N., Shimoyama, M., Inturrisi, C. E., and Elliott, K. J. (1996) Ketamine attenuates and reverses morphine tolerance in rats. Anesthesiology 85, 1357–1366.

    Article  PubMed  CAS  Google Scholar 

  56. Kolesnikov, Y. A. and Pastemak, G. W. (1999) Peripheral blockade of topical morphine tolerance by ketamine. Eur. J. Pharmacol. 374, R1 — R2.

    Article  PubMed  CAS  Google Scholar 

  57. Elliott, K., Hynansky, A., and Inturrisi, C. E. (1994) Dextromethorphan attenuates and reverses analgesic tolerance to morphine. Pain 59, 361–368.

    Article  PubMed  CAS  Google Scholar 

  58. Mao, J., Price, D. D., Caruso, F. S., and Mayer, D. J. (1996) Oral administration of dextromethorphan prevents the development of morphine tolerance and dependence in rats. Pain 67, 361–368.

    Article  PubMed  CAS  Google Scholar 

  59. Popik, P. and Kozela, E. (1999) Clinically available NMDA antagonist, memantine, attenuates tolerance to analgesic effects of morphine in a mouse tail flick test. Pol. J. Pharmacol. 51, 223–231.

    PubMed  CAS  Google Scholar 

  60. Cao, Y. J. and Bhargava, H. N. (1997) Effects of ibogaine on the development of tolerance to antinociceptive action of mu-, delta-and kappa-opioid receptor agonists in mice. Brain Res. 752, 250–254.

    Article  PubMed  CAS  Google Scholar 

  61. Davis, A. M. and Inturrisi, C. E. (1999) d-Methadone blocks morphine tolerance and N-methyl-D-aspartate-induced hyperalgesia. J. Pharmacol. Exp. Thee. 289, 1048–1053.

    Google Scholar 

  62. Kolesnikov, Y. A., Ferkany, J., and Pasternak, G. W. (1993) Blockade of mu and kappa; opioid analgesic tolerance by NPC17742, a novel NMDA antagonist. Life Sci. 53, 1489–1494.

    Article  PubMed  CAS  Google Scholar 

  63. Tiseo, P. J., Cheng, J., Pasternak, G. W., and Inturrisi, C. E. (1994) Modulation of morphine tolerance by the competitive Nmethyl-D-aspartate receptor antagonist LY274614: assessment of opioid receptor changes. J. Pharmacol. Exp. Ther. 268, 195–201.

    PubMed  CAS  Google Scholar 

  64. Allen, R. M. and Dykstra, L. A. (1999) The competitive NMDA receptor antagonist LY235959 modulates the progression of morphine tolerance in rats. Psychopharmacology 142, 209–214.

    Article  PubMed  CAS  Google Scholar 

  65. Allen, R. M., and Dykstra, L. A. (2000) Role of morphine maintenance dose in the development of tolerance and its attenuation by an NMDA receptor antagonist. Psychopharmacology 148, 59–65.

    Article  PubMed  CAS  Google Scholar 

  66. Kolesnikov, Y., Maccechini, M. L., and Pastemak, G. W. (1994) 1-Aminocyclopropane carboxylic acid (ACPC) prevents mu and delta opioid tolerance. Life Sci. 55, 1393–1398.

    Google Scholar 

  67. Lutfy, K., Shen, K. Z., Kwon, I. S., et al. (1995) Blockade of morphine tolerance by ACEA-1328, a novel NMDA receptor/glycine site antagonist. Eur. J. Pharmacol. 273, 187–189.

    Article  PubMed  CAS  Google Scholar 

  68. Lutfy, K., Doan, P., and Weber, E. (1999) ACEA-1328 a NMDA receptor/glycine site antagonist, acutely potentiates antinociception and chronically attenuates tolerance induced by morphine. Pharmacol. Res. 40, 435–442.

    Article  PubMed  CAS  Google Scholar 

  69. Bhargava, H. N. (1994) Diversity of agents that modify opioid tolerance, physical dependence, abstinence syndrome, and self-administrative behavior. Pharmacol. Rev. 46, 293–324.

    PubMed  CAS  Google Scholar 

  70. Trujillo, K. A. (2000) Are NMDA receptors involved in opiate-induced neural and behavioral plasticity? A review of pre-clinical findings. Psychopharmacology 151, 121–141.

    Article  PubMed  CAS  Google Scholar 

  71. Herman, B. H., Vocci, F., and Bridge, P. (1995) The effects of NMDA receptor antagonists and nitric oxide synthase inhibitors on opioid tolerance and withdrawal. Medication development issues for opiate addiction. Neuropsychophannacology 13, 269–293.

    Article  CAS  Google Scholar 

  72. Inturrisi, C. E. (1997) Preclinical evidence for a role of glutamatergic systems in opioid tolerance and dependence. Semin. Neurosci. 9, 110–119.

    Article  CAS  Google Scholar 

  73. Pasternak, G. W., Kolesnikov, Y. A., and Babey, A. M. (1995) Perspectives on the N-methyl-D-aspartate/nitric oxide cascade and opioid tolerance. Neuropsychopharmacology 13, 309–313.

    Article  PubMed  CAS  Google Scholar 

  74. Jeziorski, M., White, F. J., and Wolf, M. E. (1994) MK-801 prevents the development of behavioral senstization during repeated morphine administration. Synapse 16, 137–147.

    Article  PubMed  CAS  Google Scholar 

  75. Tzschentke, T. M. and Schmidt, W. J. (1996) Procedural examination of behavioral sensitisation to morphine: lack of blockade by MK-801, occurrence of sensitised sniffing, and evidence for cross-sensitisation between morphine and MK-801. Behay. Pharmacol. 7, 169–184.

    CAS  Google Scholar 

  76. Swadley-Lewellen, R. M. and Trujillo, K. A. (1998) Are NMDA receptors involved in tolerance and sensitization to the locomotor effects of morphine? Soc. Neurosci. Abstr.. 24, 19–68.

    Google Scholar 

  77. Bespalov, A. Y., Balster, R. L., and Beardsley, P. M. (1999) N-Methyl-D-aspartate receptor antagonists and the development of tolerance to the discriminitive stimulus effects of morphine in rats. J. Pharmacol. Exp. Ther. 290, 20–27.

    PubMed  CAS  Google Scholar 

  78. Babbini, M. and Davis, W. M. (1972) Time-dose relationships for locomotor activity effects of morphine after acute or repeated treatment. Br. J. Pharmacol. 46, 213–224.

    Article  PubMed  CAS  Google Scholar 

  79. Brady, L. S. and Holtzman, S. G. (1981) Locomotor behavior in morphine-dependent and post-dependent rats. Pharmacol. Biochem. Behay. 14, 361–370.

    Article  CAS  Google Scholar 

  80. Domino, E. F., Vaski, M. R., and Wilson, A. E. (1976) Mixed depressant and stimulant actions of morphine and their relationship to brain acetylcholine. Life Sci. 18, 361–376.

    Article  PubMed  CAS  Google Scholar 

  81. Bartoletti, M., Gairdi, M., Gubellini, C., Bacchi, A., and Babbini, M. (1987) Previous treatment with morphine and sensitization to the excitatory actions of opiates: dose-effect relationship. Neuropharmacology 26, 115–119.

    Article  PubMed  CAS  Google Scholar 

  82. Babbini, M., Gaiardi, M., and Bartoletti, M. (1975) Persistence of chronic morphine effects upon activity in rats 8 months after ceasing the treatment. Neuropharmacology. 14, 611–6614.

    Article  PubMed  CAS  Google Scholar 

  83. Vasko, M. R. and Domino, E. F. (1978) Tolerance development to the biphasic effects of morphine on locomotor activity and brain acetylcholine in the rat. J. Pharmacol. Exp. Ther. 207, 848–858.

    PubMed  CAS  Google Scholar 

  84. Swadley-Lewellen, R. M., Watorski, K., Warmoth, K., and Trujillo, K. A. (1998) Acute behavioral interactions between opiates and NMDA receptor antagonists in rats. NIDA Res. Monogr. 179, 95.

    Google Scholar 

  85. Trujillo, K. A. and Swadley-Lewellen, R. M. (1997) Tolerance, sensitization and physical dependence to the locomotor effects of morphine in rats. Soc. Neurosci. Abstr. 23, 2413.

    Google Scholar 

  86. Trujillo, K. A. and Watorski, K. (1999) Does MK-801 affect the expression of opiate tolerance, sensitization or physical dependence. Soc. Neurosci. Abstr. 25, 2076.

    Google Scholar 

  87. Rauhala, P., Idanpaan-Heikkila, J. J., Tuominen, R. K., and Mannisto, P. T. (1994) N-Nitro-L-arginine attenuates development of tolerance to antinociceptive but not to hormonal effects of morphine. Eur. J. Pharmacol. 259, 57–64.

    Article  PubMed  CAS  Google Scholar 

  88. Fernandes, M., Kluwe, S., and Coper, H. (1982) Development and loss of tolerance to morphine in the rat. Psychopharmacology 78, 234–238.

    Article  PubMed  CAS  Google Scholar 

  89. Rauhala, P., Idanpaan-Heikkila, J. J., Tuominen, R. K., and Mannisto, P. T. (1995) Differential disappearance of tolerance to thermal, hormonal and locomotor effects of morphine in the male rat. Eur. J. Pharmacol. 285, 69–77.

    Google Scholar 

  90. Mannisto, P. T., Borisenko, S. A., Rauhala, P., Tuomainen, P., and Tuominen, R. K. (1994) Variation in tolerance to the antinociceptive, hormonal and thermal effects of morphine after a 5-day pre-treatment of male rats with increasing doses of morphine. Naunyn-Schmiedebergs Arch. Pharmacol. 349, 161–169.

    PubMed  CAS  Google Scholar 

  91. Cox, B. M. (1991) Molecular and cellular mechanisms in opioid tolerance, in Towards a New Pharmacotherapy of Pain ( Basbaum, A. I. and Besson, J.-M., eds.), Wiley, New York, pp. 137–156.

    Google Scholar 

  92. Cox, B. M. and Werling, L. L. (1991) Opioid tolerance and dependence, in The Biological Basis of Drug Tolerance and Dependence, ( Pratt, J. A., ed.), Academic, San Diego, CA, pp. 199–229.

    Google Scholar 

  93. Trujillo, K. A. (1999) Cellular and molecular and mechanisms of opioid tolerance and dependence: progress and pitfalls. Pain Forum 8, 29–33.

    Article  Google Scholar 

  94. Nestler, E. J. and Aghajanian, E. J. (1997) Molecular and cellular basis of addiction. Science 278, 58–63.

    Google Scholar 

  95. Wolf, M. E., and Jeziorski, M. (1993) Coadministration of MK-801 with amphetamine, cocaine or morphine prevents rather than transiently masks the development of behavioral sensitization. Brain Res. 613, 291–294.

    Article  PubMed  CAS  Google Scholar 

  96. Vanderschuren, L. J., Schoffelmeer, A. N., and De Vries, T. J. (1997) Does dizocilpine (MK-801) inhibit the development of morphine-induced behavioral sensitization in rats? Life Sci. 61, 427–433.

    Article  Google Scholar 

  97. Iijima, Y., Asami, T., and Kurihara, H. (1996) Modification by MK-801 (dizocilpine), a noncompetitive NMDA receptor antagonist, of morphine sensitization: evaluation by ambulation in mice. Jpn. J. Psychopharmacol. 16, 11–18.

    CAS  Google Scholar 

  98. Livezey, R. T., Pearce, L. B., and Kornetsky, C. (1995) The effect of MK-801 and SCH23390 on the expression and sensitization of morphine-induced oral stereotypy. Brain Res. 692, 93–98.

    Article  PubMed  CAS  Google Scholar 

  99. Stephens, D. N. (1995) A glutamatergic hypothesis of drug dependence: extrapolations from benzodiazepine receptor ligands. Behay. Pharmacol. 6, 425–446.

    CAS  Google Scholar 

  100. Kalivas, P. W. (1995) Interactions between dopamine and excitatory amino acids in behavioral sensitization to psychostimulants. Drug Alcohol Depend. 37, 95–100.

    Article  PubMed  CAS  Google Scholar 

  101. Ben-Eliyahu, S., Marek, P., Vaccarino, A. L., et al. (1992) The NMDA receptor antagonist MK-801 prevents long-lasting non-associative morphine tolerance in the rat. Brain Res. 575, 304–308.

    Article  PubMed  CAS  Google Scholar 

  102. Fundytus, M. E. and Coderre, T. J. (1994) Effects of activity at metabotropic, as well as ionotropic (NMDA), glutamate recepotrs on morphine dependence. Br. J. Pharmacol. 113, 1215–1220.

    Article  PubMed  CAS  Google Scholar 

  103. Makimura, M., Sugimoto, H., Shinomiya, K., Kabasawa, Y., and Fukuda, H. (1996) Inhibitory effect of the NMDA receptor antagonist, dizocilpine (MK-801), on the development of morphine dependence. J. Toxicol. Sci. 21, 135–141.

    Article  PubMed  CAS  Google Scholar 

  104. Shoemaker, W. J., Kosten, T. A., and Muly, S. M. (1997) Ethanol attenuation of morphine dependence: comparison to dizocilpine. Psychopharmacology 134, 83–87.

    Article  PubMed  CAS  Google Scholar 

  105. Laulin, J.-P., Larher, A., Celerier, E., Le Moal, M., and Simonnet, G. (1998) Long-lasting increased pain sensitivity in rat following exposure to heroin for the first time. Eur. J. Neurosci. 10, 782–785.

    Article  PubMed  CAS  Google Scholar 

  106. Celerier, E., Laulin, J., Larcher, A., Le Moal, M., and Simonnet, G. (1999) Evidence for opiate-activated NMDA processes masking opiate analgesia in rats. Brain Res. 847, 18–25.

    Article  PubMed  CAS  Google Scholar 

  107. Celerier, E., Rivat, C., Jun, Y., et al. (2000) Long-lasting hyperalgesia induced by fentanyl in rats: preventive effect of ketamine [see comments]. Anesthesiology 92, 465–472.

    Article  PubMed  CAS  Google Scholar 

  108. Zhu, H. and Ho, I. K. (1998) NMDA-R1 antisense oligonucleotide attenuates withdrawal signs from morphine. Eur. J. Pharmacol. 352, 151–156.

    Article  PubMed  CAS  Google Scholar 

  109. Koyuncuoglu, H., Gungor, M., Sagduyu, H., and Aricioglu, F. (1990) Suppression by ketamine and dextromethorphan of precipitated abstinence syndrome in rats. Pharmacol. Biochem. Behay. 35, 829–832.

    Article  CAS  Google Scholar 

  110. Koyuncuoglu, H. and Saydam, B. (1990) The treatment of heroin addicts with dextromethorphan. A double-blind comparison of dextromethorphan with chlorpromazine. Int. J. Clin. Pharmacol. Ther. Toxicol. 28, 147–452.

    PubMed  CAS  Google Scholar 

  111. Rasmussen, K., Krystal, J. H., and Aghajanian, G. K. (1991) Excitatory amino acids and morphine withdrawal: differential effects of central and peripheral kynurenic acid administration. Psychopharmacology 105, 508–512.

    Article  PubMed  CAS  Google Scholar 

  112. Rasmussen, K., Fuller, R. W., Stockton, M. E., et al. (1991) NMDA receptor antagonists suppress behaviors but not norepinephrine turnover or locus coeruleus unit activity induced by opiate withdrawal. Eur. J. Pharmacol. 197, 9–16.

    Article  PubMed  CAS  Google Scholar 

  113. Tanganelli, S., Antonelli, T., Morari, M., Bianchi, C., and Beani, L. (1991) Glutamate antagonists prevent morphine withdrawal in mice and guinea pigs. Neurosci. Lett. 122, 270–272.

    Article  PubMed  CAS  Google Scholar 

  114. Koyuncuoglu, H., Dizdar, Y., Aricioglu, F., and Sayin, U. (1992) Effects of MK-801 on morphine physical dependence: attenuation and intensification. Pharmacol. Biochem. Behay. 43, 487–490.

    Article  CAS  Google Scholar 

  115. Higgins, G. A., Nguyen, P., and Sellers, E. M. (1992) The NMDA antagonist dizocilpine (MK-801) attenuates motivational as well as somatic aspects of naloxone precipitated opioid withdrawal. Life Sci. 50, PL167–PL172.

    Google Scholar 

  116. Brent, P. J., and Chahl, L. A. (1993) Enhancement of the opiate withdrawal response by antipsychotic drugs in guinea pigs is not mediated by sigma binding sites. Eur. Neuropsychopharmacol. 3, 23–32.

    Article  PubMed  CAS  Google Scholar 

  117. Cappendijk, S. L. T., de Vries, R., and Dzoljic, M. R. (1993) Excitatory amino acid receptor antagonists and naloxone-precipitated withdrawal syndrome in morphine-dependent mice. Eur. Neuropsychopharmacol. 3, 111–116.

    Article  PubMed  CAS  Google Scholar 

  118. Popik, P. and Skolnick, P. (1996) The NMDA antagonist memantine blocks the expression and maintenance of morphine dependence. Pharmacol. Biochem. Behay. 53, 791–797.

    Article  CAS  Google Scholar 

  119. Popik, P. and Danysz, W. (1997) Inhibition of reinforcing effects of morphine and motivational aspects of naloxone-precipdated opioid withdrawal by N-methyl-n-aspartate receptor antagonist, memantine. J. Pharmacol. Exp. Ther. 280, 854–865.

    PubMed  CAS  Google Scholar 

  120. Popik, P., Mamczarz, J., Fraczek, M., et al. (1998) Inhibition of reinforcing effects of morphine and naloxone-precipitated opioid withdrawal by novel glycine site and uncompetitive NMDA receptor antagonists. Neuropharmacology 37, 1033–1042.

    Article  PubMed  CAS  Google Scholar 

  121. Bristow, L. J., Hogg, J. E., and Hutson, R. H. (1997) Competitive and glycine/NMDA receptor antagonists attenuate withdrawal-induced behaviors and increased hippocampal acetylcholine efflux in morphine-dependent rats. Neuropharmacology 36, 241–250.

    Article  PubMed  CAS  Google Scholar 

  122. Medvedev, I. O., Dravolina, O. A., and Bespalov, A. Y. 1998. Effects of N-methyl-D-aspartate receptor antagonists on discriminative stimulus effects of naloxone in morphine-dependent rats using the Y-maze drug discrimination paradigm. J. Pharmacol. Exp. Thee. 286, 1260–1268.

    CAS  Google Scholar 

  123. Belozertseva, I. V., Danysz, W., and Bespalov, A. Y. (2000) Short-acting NMDA receptor antagonist MRZ 2/576 produces prolonged suppression of morphine withdrawal in mice. Naunyn-Schmiedebergs Arch. Phannacol. 361, 279–282.

    Article  CAS  Google Scholar 

  124. Bläsig, J., Herz, A., Reinhold, K., and Zieglgänsberger, S. (1973) Development of physical dependence on morphine in respect to time and dosage and quantification of the precipitated withdrawal syndrome in rats. Psychopharmacology 33, 19–38.

    Article  Google Scholar 

  125. Trujillo, K. A. and Akil, H. (1993) Does MK-801 block naloxone-precipitated opiate withdrawal? Soc. Neurosci. Abstr. 19, 1246.

    Google Scholar 

  126. Trujillo, K. A. (1995) Effects of non-competitive N-methyl-n-aspartate receptor antagonists on opiate tolerance and physical dependence. Neuropsychopharmacology 13, 301–307.

    Article  PubMed  CAS  Google Scholar 

  127. Popik, R, Kozela, E., and Danysz, W. (2000) Clinically available NMDA receptor antagonists memantine and dextromethorphan reverse existing tolerance to the antinociceptive effects of morphine in mice. Naunyn-Schmiedebergs Arch. Pharmacol. 361, 425–432.

    Article  PubMed  CAS  Google Scholar 

  128. Commons, K. G., van Bockstaele, E. J., and Pfaff, D. W. (1999) Frequent colocalization of mu opioid and NMDA-type glutamate receptors at postsynaptic sites in periaqueductal gray neurons. J. Comp. Neurol. 408, 549–559.

    Article  PubMed  CAS  Google Scholar 

  129. Gracy, K. N., Svingos, A. L., and Pickel, V. M. 1997. Dual ultrastructural localization of mu-opioid receptors and NMDAtype glutamate receptors in the shell of the rat nucleus accumbens. J Neurosci. 17, 4839–4848.

    PubMed  CAS  Google Scholar 

  130. Wang, H., Gracy, K. N., and Pickel, V. M. (1999) Mu-opioid and NMDA-type glutamate receptors are often colocalized in spiny neurons within patches of the caudate-putamen nucleus. J. Comp. Neurol. 412, 132–146.

    Article  PubMed  CAS  Google Scholar 

  131. Chen, L. and Huang, L. Y. (1991) Sustained potentiation of NMDA receptor-mediated glutamate responses through activation of protein kinase C by a mu opioid. Neuron 7, 319–326.

    Article  PubMed  Google Scholar 

  132. Chen, L. and Huang, L. Y. (1992) Protein kinase C reduces Mg++ block of NMDA-receptor channels as a mechanism of modulation. Nature 356, 521–523.

    Article  PubMed  CAS  Google Scholar 

  133. Fan, G.-H., Zhao, J., Wu, Y. L., et al. (1998) N-Methyl-D-aspartate attenuates opioid receptor-mediated G protein activation and this process involves protein kinase C. Mol. Pharmacol. 53, 684–690.

    PubMed  CAS  Google Scholar 

  134. Martin, G., Przewlocki, R., and Siggins, G. R. (1999) Chronic morphine treatment selectively augments metabotropic glutamate receptor-induced inhibition of N-methyl-D-aspartate receptor-mediated neurotransmission in nucleus accumbens. J. Pharmacol. Exp. Ther. 288, 30–35.

    PubMed  CAS  Google Scholar 

  135. Martin, G., Nie, Z., and Siggins, G. R. (1997) Mu-Opioid receptors modulate NMDA receptor-mediated responses in nucleus accumbens neurons. J. Neurosci. 17, 11–22.

    PubMed  CAS  Google Scholar 

  136. Mao, J., Price, D. D., and Mayer, D. J. (1995) Mechanisms of hyperalgesia and morphine tolerance: a current view of their possible interactions. Pain 62, 259–274.

    Article  PubMed  CAS  Google Scholar 

  137. Mayer, D. J., Mao, J., and Price, D. D. (1995) The association of neuropathie pain, morphine tolerance and dependence, and the translocation of protein kinase C. NIDA Res. Monogr. 147, 269–298.

    PubMed  CAS  Google Scholar 

  138. Mayer, D. J. and Mao, J. (1999) Mechanisms of opioid tolerance: a current view of cellular mechanisms. Pain Forum 8, 14–18.

    Article  Google Scholar 

  139. Fundytus, M. E. and Coderre, T. J. (1999) Opioid tolerance and dependence: a new model highlighting the role of metabotropic glutamate receptors. Pain Forum 8, 3–13.

    Article  Google Scholar 

  140. Mayer, D. J., Mao, J., and Price, D. D. (1995) The development of morphine tolerance and dependence is associated with translocation of protein kinase C. Pain 61, 365–374.

    Article  PubMed  CAS  Google Scholar 

  141. Mestek, A., Hurley, J. H., Bye, L. S., et al. (1995) The human mu opioid receptor: modulation of functional desensitization by calcium/calmodulin-dependent protein kinase and protein kinase C. J. Neurosci. 15, 2396–2406.

    PubMed  CAS  Google Scholar 

  142. Narita, M., Makimura, M., Feng, Y., Hoskins, B., and Ho, I. K. (1994) Influence of chronic morphine treatment on protein kinase C activity: comparison with butorphanol and implication for opioid tolerance. Brain Res. 650, 175–179.

    Article  PubMed  CAS  Google Scholar 

  143. Makimura, M., Iwai, M., Sugimoto, H., and Fukuda, H. (1997) Effect of NMDA receptor antagonists on protein kinase activated by chronic morphine treatment. J. Toxicol. Sci. 22, 59–66.

    Article  Google Scholar 

  144. Ventayol, P., Busquets, X., and Garcia-Sevilla, J. A. (1997) Modulation of immunoreactive protein kinase C-alpha and beta isoforms and G proteins by acute and chronic treatments with morphine and other opiate drugs in rat brain. NaunynSchmiedebergs Arch. Pharmacol. 355, 491–500.

    Article  PubMed  CAS  Google Scholar 

  145. Li, Y., and Roerig, S. C. (1999) Alteration of spinal protein kinase C expression and kinetics in morphine, but not clonidine, tolerance. Biochem. Pharmacol. 58, 493–501.

    Article  PubMed  CAS  Google Scholar 

  146. Smart, D., and Lambert, D. G. (1996) The stimulatory effects of opioids and their possible role in the development of tolerance. Trends Pharmacol. Sci. 17, 264–269.

    Article  PubMed  CAS  Google Scholar 

  147. Smith, F. L., Lohmann, A. B., and Dewey, W. L. (1999) Involvement of phospholipid signal transduction in morphine tolerance in mice. Br. J. Pharmacol. 128, 220–226.

    Article  PubMed  CAS  Google Scholar 

  148. Smart, D., Hirst, R. A., Hirota, K., Grandy, D. K., and Lambert, D. G. (1997) The effects of recominant rat.t-opioid receptor activation in CHO cell on phospholipase C, [Ca2+]; and adenylyl cyclase. Br. J. Pharmacol. 120, 1165–1171.

    Article  PubMed  CAS  Google Scholar 

  149. Ueda, H., Miyamae, T., Fukushima, N., et al. (1995) Opioid µ- and x-receptor mediate phospholipase C activation through G,1 in Xenopus oocytes. Mol. Brain Res. 32, 166–170.

    Article  CAS  Google Scholar 

  150. Xie, W., Samoriski, G. M., McLaughlin, J. P., et al. (1999) Genetic alterations of phospholipase C ß3 expression modulates behavioral and cellular responses to µ opioids. Proc. Natl. Acad. Sci. USA 96, 10, 385–10, 390.

    Google Scholar 

  151. Przewlocki, R., Parsons, K. L., Sweeney, D. D., et al. (1999) Opioid enhancement of calcium oscillations and burst events involving NMDA receptors and L-type calcium channels in cultured hippocampal neurons. J. Neurosci. 19, 9705–9715.

    PubMed  CAS  Google Scholar 

  152. Narita, M., Narita, M., Mizoguchi, H., and Tseng, L. F. (1995) Inhibition of protein kinase C, but not of protein kinase A, blocks the development of acute antinociceptive tolerance to an intrathecally administered.t-opioid receptor agonist in the mouse. Eur. J. Pharmacol. 280, RI—R3.

    Google Scholar 

  153. Granados-Soto, V., Kalcheva, I., Hua, X., Newton, A., and Yaksh, T. L. (2000) Spinal PKC activity and expression: role in tolerance produced by continuous spinal morphine infusion. Pain 85, 395–404.

    Article  PubMed  CAS  Google Scholar 

  154. Inoue, M., and Ueda, H. (2000) Protein kinase C-mediated acute tolerance to peripheral mu-opioid analgesia in the bradykinin-nociception test in mice. J. Pharmacol. Exp. Thee. 293, 662–669.

    CAS  Google Scholar 

  155. Fundytus, M. E., and Coderre, T. J. (1996) Chronic inhibition of intracellular Ca2+ release or protein kinase C activation significantly reduces the development of morphine dependence. Eue J. Pharmacol. 300, 173–181.

    Article  CAS  Google Scholar 

  156. Xu, J. Y., Hill, K. P., and Bidlack, J. M. (1998) The nitric oxide/cyclic GMP system at the supraspinal site is involved in the development of acute morphine antinociceptive tolerance. J. Pharmacol. Exp. Thee 284, 196–201.

    CAS  Google Scholar 

  157. Fan, G.-H., Wang, L.-Z., Qiu, H.-C., Ma, L., and Pei, G. (1999) Inhibition of calcium/calmodulin-dependent protein kinase II in rat hippocampus attenuates morphine tolerance and dependence. Mol. Pharm. 56, 39–45.

    CAS  Google Scholar 

  158. Cai, Y.-C., Ma, L., Fan, G.-H., et al. (1997) Activation of N-methyl-D-aspartate receptor attenuates acute responsiveness of 8-opioid receptors. Mol. Pharm. 51, 583–587.

    CAS  Google Scholar 

  159. Chen, Y. and Yu, L. (1994) Differential regulation by cAMP-dependent protein kinase and protein kinase C of the µ opioid receptor coupling to a G protein-activated K+ channel. J. Biol. Chem. 269, 7839–7842.

    PubMed  CAS  Google Scholar 

  160. Zhang, L., Yu, Y., Mackin, S., et al. (1996) Differential µ opiate receptor phosphorylation and desensitization induced by agonists and phorbol esters. J. Biol. Chem. 271, 11,449–11, 454.

    Google Scholar 

  161. Childers, S. (1993) Opioid receptor-coupled second messenger systems, in Opioids I Akil, H. and Simon, E. J., eds.), Springer-Verlag, New York, pp. 189–216.

    Google Scholar 

  162. Jordan, B. and Devi, L. A. (1998) Molecular mechanisms of opioid receptor signal transduction. Br. J. Anaesth. 81, 12–19.

    Article  PubMed  CAS  Google Scholar 

  163. Law, P.-Y., Wong, Y. H., and Loh, H. H. (2000) Molecular mechanisms and regulation of opioid receptor signalling. Annu. Rev. Pharmacol. Toxicol. 40, 389–430.

    Article  PubMed  CAS  Google Scholar 

  164. Wang, L. and Gintzler, A. R. (1995) Morphine tolerance and physical dependence: reversal of opioid inhibition to enhancement of cyclic AMP formation. J. Neurochem. 64, 1102–1106.

    Article  PubMed  CAS  Google Scholar 

  165. Crain, S. M., and Shen, K.-F. (1990) Opioids can evoke direct receptor-mediated excitatory effects on sensory neurons. Trends Pharmacol. Sci. 11, 77–81.

    Article  PubMed  CAS  Google Scholar 

  166. Crain, S. M., and Shen, K.-F. (1998) Modulation of opioid analgesia, tolerance and dependence by Gs-coupled, GM 1 ganglioside-regulated opioid receptor functions. Trends Pharmacol. Sci. 19, 358–365.

    Article  PubMed  CAS  Google Scholar 

  167. Crain, S. M. and Shen, K.-F. (1996) Modulatory effects of Gs-coupled excitatory opioid receptor functions on opioid analgesia, tolerance and dependence. Neurochem. Res. 21, 1347–1351.

    Article  PubMed  CAS  Google Scholar 

  168. Wang, L., Medina, V. M., Rivera, M., and Gintzler, A. R. (1996) Relevance of phosphorylation state to opioid responsiveness in opiate naive and tolerant/dependent tissue. Brain Res. 723, 61–69.

    Article  PubMed  CAS  Google Scholar 

  169. Wang, L., and Gintzler, A. R. 1997. Altered mu-opiate receptor-G protein signal transduction following chronic morphine exposure. J. Neurochem. 68, 248–254.

    Article  PubMed  CAS  Google Scholar 

  170. Sadee, W. and Wang, Z. (1995) Agonist induced constitutive receptor activation as a novel regulatory mechanism. Mu receptor regulation. Adv. Exp. Med. Biol. 373, 85–90.

    Article  PubMed  CAS  Google Scholar 

  171. Wang, Z., Bilsky, E. J., Porreca, F., and Sadee, W. (1994) Constituitive opioid receptor activation as a regulatory mechanism underlying narcotic tolerance and dependence. Life Sci. 54, PL339–PL350.

    Google Scholar 

  172. Martin, G., Ahmed, S. H., Blank, T., et al. (1999) Chronic morphine treatment alters NMDA receptor-mediated synaptic transmission in the nucleus accumbens. J. Neurosci. 19, 9081–9089.

    PubMed  CAS  Google Scholar 

  173. Rothman, R. B. (1992) A review of the role of anti-opioid peptides in morphine tolerance and dependence. Synapse 12, 129–138.

    Article  PubMed  CAS  Google Scholar 

  174. Trujillo, K. A., Bronstein, D. M., and Akil, H. (1993) Regulation of opioid peptides by self-administered drugs, in The Neurobiology of Opiates ( Hammer, R. P., Jr., ed.), CRC, Boca Raton, FL, pp. 223–256.

    Google Scholar 

  175. Tiffany, S. T., and Maude-Griffith, P. M. (1988) Tolerance to morphine in the rat: associative and non-associative effects. Behay. Neurosci. 102, 534–543.

    Article  CAS  Google Scholar 

  176. Dray, A. and Urban, L. (1996) New pharmacological strategies for pain relief. Annu. Rev. Pharmacol. Toxicol. 36, 253–280.

    Article  PubMed  CAS  Google Scholar 

  177. Grass, S., Hoffmann, O., Xu, X. J., and Wiesenfeld, Z. (1996) N-methyl-D-aspartate receptor antagonists potentiate morphine’s antinociceptive effect in the rat. Acta Physiol. Scand. 158, 269–273.

    Article  PubMed  CAS  Google Scholar 

  178. Hoffmann, O. and Wiesenfeld, Z. (1996) Dextromethorphan potentiates morphine antinociception, but does not reverse tolerance in rats. NeuroReport 7, 838–840.

    CAS  Google Scholar 

  179. Bespalov, A., Kudryashova, M., and Zvartau, E. (1998) Prolongation of morphine analgesia by competitive NMDA receptor antagonist D-CPPene (SDZ EAA 494) in rats. Eue J. Pharmacol. 351, 299–305.

    Article  CAS  Google Scholar 

  180. Advokat, C. and Rhein, F. Q. (1995) Potentiation of morphine-induced antinociception in acute spinal rats by the NMDA antagonist dextrorphan. Brain Res. 699, 157–160.

    Article  PubMed  CAS  Google Scholar 

  181. Belozertseva, I. V., Dravolina, O. A., Neznanova, O. N., Danysz, W., and Bespalov, A. Y. 2000. Antinociceptive activity of combination of morphine and NMDA receptor antagonists depends on the inter-injection interval. Eue. J. Pharmacol. 396, 77–83.

    Article  CAS  Google Scholar 

  182. Goldblum, R. (2000) Long-term safety of MorphiDex. J. Pain Symptom Manage. 19, S50 - S56.

    Article  PubMed  CAS  Google Scholar 

  183. Chevlen, E. (2000) Morphine with dextromethorphan: conversion from other opioid analgesics. J. Pain Symptom Manage. 19, S42 - S49.

    Article  PubMed  CAS  Google Scholar 

  184. Katz, N. P. (2000) MorphiDex (MS: DM) double-blind, multiple-dose studies in chronic pain patients. J. Pain Symptom Manage. 19, S37 - S41.

    Article  PubMed  CAS  Google Scholar 

  185. Caruso, F. S. (2000) MorphiDex pharmacokinetic studies and single-dose analgesic efficacy studies in patients with postoperative pain. J. Pain Symptom Manage. 19, S31 - S36.

    Article  PubMed  CAS  Google Scholar 

  186. Koyuncuoglu, H. (1995) The combination of tizanidine markedly improves the treatment with dextromethorphan of heroin addicted outpatients. Int. J. Clin. Pharmacol. Thee. 33, 13–19.

    CAS  Google Scholar 

  187. Rosen, M. I., Pearsall, H. R., and Kosten, T. R. (1998) The effect of lamotrigine on naloxone-precipitated opiate withdrawal. Drug Alcohol Depend. 52, 173–176.

    Article  PubMed  CAS  Google Scholar 

  188. Rosen, M. I., McMahon, T. J., Woods, S. W., Pearsall, H. R., and Kosten, T. R. (1996) A pilot study of dextromethorphan in naloxone-precipitated opiate withdrawal. Eue. J. Pharmacol. 307, 251–257.

    Article  CAS  Google Scholar 

  189. Alper, K. R., Lotsof, H. S., Frenken, G. M., Luciano, D. J., and Bastiaans, J. (1999) Treatment of acute opioid withdrawal with ibogaine. Am. J. Addict. 8, 234–242.

    Article  PubMed  CAS  Google Scholar 

  190. Mash, D. C., Kovera, C. A., Buck, B. E., et al. (1998) Medication development of ibogaine as a pharmacotherapy for drug dependence. Ann. NYAcad. Sci. 844, 274–292.

    Article  PubMed  CAS  Google Scholar 

  191. Itzhak, Y. and Ali, S. F. (1998) Effect of ibogaine on the various sites of the NMDA receptor complex and sigma binding sites in rat brain. Ann. NYAcad. Sci. 844, 245–251.

    Article  PubMed  CAS  Google Scholar 

  192. Layer, R. T., Skolnick, P., Bertha, C. M., et al. (1996) Structurally modified ibogaine analogs exhibit differing affinities for NMDA receptors. Eur. J. Pharmacol. 309, 159–165.

    Article  PubMed  CAS  Google Scholar 

  193. Popik, P., Layer, R. T., Fossom, L. H., et al. (1995) NMDA antagonist properties of the putative antiaddictive drug, ibogaine. J. Pharmacol. Exp. Ther. 275, 753–760.

    PubMed  CAS  Google Scholar 

  194. Popik, P., Layer, R. T., and Skolnick, R (1995) 100 years of ibogaine: neurochemical and pharmacological actions of a putative anti-addictive drug. Pharmacol. Rev. 47, 235–253.

    Google Scholar 

  195. Sheppard, S. G. (1994) A preliminary investigation of ibogaine: case reports and recommendations for further study. J. SubstAbuse Treat. 11, 379–385.

    Article  PubMed  CAS  Google Scholar 

  196. Tzschentke, T. M. and Schmidt, W. J. (1995) N-methyl-o-aspartic acid-receptor antagonists block morphine-induced conditioned place preference in rats. Neurosci. Lett. 193, 37–40.

    Article  PubMed  CAS  Google Scholar 

  197. Kim, H.-S., Jang, C.-G., and Park, W.-K. (1996) Inhibition by MK-801 of morphine-induced conditioned place preference and postsynaptic dopamine receptor supersensitivity in mice. Pharmacol. Biochem. Behay. 55, 11–17.

    Article  CAS  Google Scholar 

  198. Del Pozo, E., Barrios, M., and Baeyens, J. M. (1996) The NMDA receptor antagonist dizocilpine (MK-801) stereoselectively inhibits morphine-induced place preference conditioning in mice. Psychopharmacology 125, 209–213.

    Article  PubMed  Google Scholar 

  199. Tzschentke, T. M. and Schmidt, W. J. (1997) Interactions of MK-801 and GYKI 52466 with morphine and amphetamine in place preference conditioning and behavioural sensitization. Behay. Brain Res. 84, 99–107.

    Article  CAS  Google Scholar 

  200. Tzschentke, T. M. and Schmidt, W. J. (1998) Blockade of morphine-and amphetamine-induced conditioned place preference in the rat by riluzole. Neurosci. Lett. 242, 114–116.

    Article  PubMed  CAS  Google Scholar 

  201. Kotlinska, J. and Biala, G. (1999) Effects of the NMDA/glycine receptor antagonist, L-701,324, on morphine-and cocaine-induced place preference. Pol. J. Pharmacol. 51, 323–330.

    PubMed  CAS  Google Scholar 

  202. Suzuki, T., Kato, H., Tsuda, M., Suzuki, H., and Misawa, M. (1999) Effects of the non-competitive NMDA receptor antagonist ifenprodil on the morphine-induced place preference in mice. Life Sci. 64, L151 - L156.

    Article  Google Scholar 

  203. Semenova, S., Danysz, W., and Bespalov, A. (1999) Low-affinity NMDA receptor channel blockers inhibit acquisition of intravenous morphine self-administration in naive mice. Eur. J Pharmacol. 378, 1–8.

    Article  PubMed  CAS  Google Scholar 

  204. Tzschentke, T. M. and Schmidt, W. J. (2000) Effects of the non-competitive NMDA-receptor antagonist memantine on morphine-and cocaine-induced potentiation of lateral hypothalamic brain stimulation reward. Psychopharmacology 149, 225–234.

    Article  CAS  Google Scholar 

  205. Carlezon, W. A. and Wise, R. A. (1993) Morphine-induced potentiation of brain stimulation reward is enhanced by MK-801. Brain Res. 620, 339–342.

    Article  PubMed  Google Scholar 

  206. Bubser, M., Keseberg, U., Notz, P. K., and Schmidt, W. J. (1992) Differential behavioral and neurochemical effects of cornpetitive and non-competitive NMDA receptor antagonists in rats. Eur. J. Pharmacol. 229, 75–82.

    Article  PubMed  CAS  Google Scholar 

  207. Danysz, W., Essuran, U., Bresink, I., and Wilke, R. (1994) Glutamate antagonists have different effects on spontaneous locomotor activity in rats. Pharmacol. Biochem. Behay. 48, 111–118.

    Article  CAS  Google Scholar 

  208. Hiramatsu, M., Cho, A. K., and Nabeshima, T. (1989) Comparison of the behavioral and biochemical effects of the NMDA receptor antagonists, MK-801 and phencyclidine. Eur. J. Pharmacol. 166, 359–366.

    Article  PubMed  CAS  Google Scholar 

  209. Tricklebank, M. D., Singh, L., Oles, R. J., Preston, C., and Iversen, S. D. (1989) The behavioral effects of MK-801: a comparison with antagonists acting non-competitively and competitively at the NMDA receptor. Eur. J. Pharmacol. 167, 127–135.

    Article  PubMed  CAS  Google Scholar 

  210. Newcomer, J. W., Farber, N. B., Jevtovic-Todorovic, V., et al. (1999) Ketamine-induced NMDA receptor hypofunction as a model of memory impairment and psychosis. Neuropsychopharmacology 20, 106–118.

    Article  PubMed  CAS  Google Scholar 

  211. Jentsch, J. D. and Roth, R. H. (1999) The neuropsychopharmacology of phencyclidine: from NMDA receptor hypofunction to the dopamine hypothesis of schizophrenia. Neuropsychopharmacology 20, 201–225.

    Article  PubMed  CAS  Google Scholar 

  212. Olney, J. W. (1994) Neurotoxicity of NMDA receptor antagonists: an overview. Psychopharmacol. Bull. 30, 533–540.

    PubMed  CAS  Google Scholar 

  213. Olney, J. W. and Farber, N. B. (1995) NMDA antagonists as neurotherapeutic drugs, psychotogens, neurotoxins, and research tools for studying schizophrenia. Neuropsychopharmacology 13, 335–345.

    Article  PubMed  CAS  Google Scholar 

  214. Domino, E. F. (1990) Status of Ketamine in Anesthesiology, NPP Books, Ann Arbor, MI.

    Google Scholar 

  215. Gutstein, H. B., Johnson, K. L., Heard, M. B., and Gregory, G. A. (1992) Oral ketamine preanesthetic medication in children. Anesthesiology 76, 28–33.

    Article  PubMed  CAS  Google Scholar 

  216. Krystal, J. H., Karper, L. P., Seibyl, J. P., et al. (1994) Subanesthetic effects of the non-competitive NMDA antagonist, ketamine, in humans: psychotomimetic, perceptual, cognitive and neuroendocrine responses. Arch. Gen. Psychiatry 51, 199–214.

    Article  PubMed  CAS  Google Scholar 

  217. Marshall, B. E. and Longnecker, D. E. (1996) General anesthetics, in Goodman and Gilman’s The Pharmacological Basis of Therapeutics. ( Hardman, J. G., Limbird, L. E., Molinoff, P. B., Ruddon, K. W., and Gilman, A. G., eds.), McGraw-Hill, New York, pp. 331–348.

    Google Scholar 

  218. O’Brien, C. P. (1996) Drug addiction and drug abuse, in Goodman and Gilman’s The Pharmacological Basis of Therapeutics ( Hardman, J. G., Limbird, L. E., Molinoff, P. B., Ruddon, R. W., and Gilman, A. G., eds.), McGraw-Hill, New York, pp. 557–578.

    Google Scholar 

  219. Gorelick, D. A. and Balster, R. L. (1995) Phencyclidine (PCP), in Psychopharmacology: The Fourth Generation of Progress (Bloom, F. E. and Kupfer, D. J., eds.), Raven, New York, pp. 1767–1776.

    Google Scholar 

  220. Danysz, W. and Parsons, C. G. (1998) Glycine and N-methyl-D-aspartate receptors: physiological significance and possible therapeutic applications. Pharmacol. Rev. 50, 597–664.

    PubMed  CAS  Google Scholar 

  221. Kemp, J. A. and Leeson, P. D. (1993) The glycine site of the NMDA receptor-five years on. Trends Pharmacol. Sci. 14, 20–25.

    Article  PubMed  CAS  Google Scholar 

  222. Lipton, S. A. (1993) Prospects for clinically tolerated NMDA antagonists: open channel blockers and alternative redox states of nitric oxide. Trends Neurosci. 16, 527–532.

    Article  PubMed  CAS  Google Scholar 

  223. Rogawski, M. A. and Porter, R. J. (1990) Antiepileptic drugs: pharmacological mechanisms and clinical efficacy with consideration of promising developmental stage compounds. Pharmacol. Rev. 42, 223–286.

    PubMed  CAS  Google Scholar 

  224. Rogawski, M. A. (1993) Therapeutic potential of excitatory amino acid antagonists: channel blockers and 2,3-benzodiazepines. Trends Pharmacol. Sci. 14, 325–331.

    Article  PubMed  CAS  Google Scholar 

  225. Parsons, C. G., Danysz, W., and Quack, G. (1999) Memantine is a clinically well-tolerated N-methyl-D-aspartate (NMDA) receptor antagonists—a review of preclinical data. Neuropharmacology 38, 735–767.

    Article  PubMed  CAS  Google Scholar 

  226. Willets, J., Balster, R. L., and Leander, J. D. (1990) The behavioral pharmacology of NMDA receptor antagonists. Trends Pharmacol. Sci. 11, 423–428.

    Article  Google Scholar 

  227. Leeson, P. D. and Iversen, L. L. (1994) The glycine site on the NMDA receptor: structure–activity relationships and therapeutic potential. J. Med. Chem. 37, 4053–4065.

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. Keith A. Trujillo PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Clinical Medical Branch, Division of Treatment Research and Development, National Institute on Drug Abuse (NIDA), National Institutes of Health (NIH), Bethesda, MD, USA

    Barbara H. Herman PhD

  2. Pharmacology, Integrative & Cellular Neurobiology Research Branch (PICNRB), Division of Neuroscience & Behavioral Research (DNBR), National Institute on Drug Abuse (NIDA), National Institutes of Health (NIH), Bethesda, MD, USA

    Jerry Frankenheim PhD

  3. Treatment Research Branch, Division of Clinical and Prevention Research, National Institute on Drug Abuse (NIAAA), National Institutes of Health (NIH), Bethesda, MD, USA

    Raye Z. Litten PhD

  4. Division of Neuropharmacological Drug Products Center for Drug Evaluation and Research, Office of Drug Evaluation I, Food and Drug Administration, Rockville, MD, USA

    Philip H. Sheridan MD

  5. Laboratory of Molecular and Cellular Neurobiology, Division of Intramural Clinical and Biological Research, National Institute on Drug Abuse (NIAAA) National Institutes of Health (NIH), Bethesda, MD, USA

    Forrest F. Weight MD

  6. Division of Treatment Research and Development, National Institute on Drug Abuse (NIDA), National Institutes of Health (NIH), Bethesda, MD, USA

    Steven R. Zukin MD

Rights and permissions

Reprints and permissions

Copyright information

© 2002 Springer Science+Business Media New York

About this chapter

Cite this chapter

Trujillo, K.A. (2002). The Role of NMDA Receptors in Opiate Tolerance, Sensitization, and Physical Dependence. In: Herman, B.H., Frankenheim, J., Litten, R.Z., Sheridan, P.H., Weight, F.F., Zukin, S.R. (eds) Glutamate and Addiction. Contemporary Clinical Neuroscience. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-306-4_20

Download citation

  • DOI: https://doi.org/10.1007/978-1-59259-306-4_20

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-61737-234-6

  • Online ISBN: 978-1-59259-306-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation